Articles

Results 1 to 5 of 17
Most popular |Most recent


New FTC reporting rules target pharma and biotech patent licenses

USA - November 11 2013 The Federal Trade Commission ("FTC") is now targeting pharma and biotech patent license agreements in which less than all the patent rights are…

Jennifer J. Daniels, Michael J. Medveckus.

New U.S. patent rule changes: permits delayed priority claim after 12-month Paris Convention time period

USA - November 5 2013 The U.S. Patent and Trademark Office has announced several patent rule changes to implement the Patent Law Treaties Implementation Act of 2012. The…

Litigation after the AIA: more of the same?

USA - June 3 2013 Two provisions of the September 2011 Leahy-Smith America Invents Act (“AIA”) were adopted in an apparent attempt to reform certain aspects of patent…

Bruce D. George, Michael C. Greenbaum, Peter S. Weissman, Tara Laster Marcus.

Inter Partes Review

USA - May 20 2013 Inter Partes Review is a new post-grant proceeding created by the AIA for challenging a patent. Inter Partes Review replaces and improves upon Inter…

Bruce D. George, Michael C. Greenbaum, Peter S. Weissman, Tara Laster Marcus.

Reduced “micro entity” government fees available for certain patent applicants

USA - April 2 2013 The United States Patent and Trademark Office (USPTO) has established rules and a fee schedule providing a 75% "micro entity" discount for many fees…

Bruce D. George, David J. Edmondson, Michael C. Greenbaum, Peter S. Weissman, Tara Laster Marcus.